Insider · CIK 0001250277
Paul F Jacobson
Files at THRN (Thorne Healthtech, Inc.). First filing -, latest -.
In brief
Paul F Jacobson files SEC Form 4 as CEO, director and 10% owner at THRN (Thorne Healthtech, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Paul F Jacobson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | THRN Thorne Healthtech, Inc. | DDisposition to issuer Common Stock | -2,105,589 | - | - | 0 | Oct 18, 2023 |
| Apr 4, 2023 | THRN Thorne Healthtech, Inc. | FTax withholding Common Stock | -45,338 | $4.72 | $214k | 1,825,966 | Oct 18, 2023 |
| Mar 24, 2023 | THRN Thorne Healthtech, Inc. | FTax withholding Common Stock | -59,907 | $4.70 | $282k | 1,871,304 | Oct 18, 2023 |
| Oct 16, 2023 | THRN Thorne Healthtech, Inc. | DDisposition to issuer Common Stockindirect: See Footnote | -220,377 | - | - | 0 | Oct 18, 2023 |
| Oct 16, 2023 | THRN Thorne Healthtech, Inc. | DDisposition to issuer Common Stockindirect: See Footnote | -1,602,445 | - | - | 0 | Oct 18, 2023 |
| Oct 16, 2023 | THRN Thorne Healthtech, Inc. | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -208,100 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | THRN Thorne Healthtech, Inc. | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -244,750 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | THRN Thorne Healthtech, Inc. | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -244,750 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | THRN Thorne Healthtech, Inc. | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -1,279,375 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | THRN Thorne Healthtech, Inc. | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -36,045 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | THRN Thorne Healthtech, Inc. | DDisposition to issuer Warrant (Right to buy)derivativeindirect: See Footnote | -2,532,050 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Apr 4, 2023 | THRN Thorne Healthtech, Inc. | FTax withholding Common Stock | -40,556 | $4.72 | $191k | 1,838,036 | Apr 6, 2023 |
| Apr 4, 2023 | THRN Thorne Healthtech, Inc. | AGrant or award Common Stock | +500,000 | $0.00 | $0 | 2,338,036 | Apr 6, 2023 |
| Mar 24, 2023 | THRN Thorne Healthtech, Inc. | FTax withholding Common Stock | -52,619 | $4.70 | $247k | 1,878,592 | Mar 28, 2023 |
| Dec 1, 2022 | THRN Thorne Healthtech, Inc. | FTax withholding Common Stock | -45,338 | $4.89 | $222k | 1,931,211 | Dec 5, 2022 |
Questions about Paul F Jacobson
Answered from the filings on this page, as of the latest one.
Is Paul F Jacobson buying or selling?
Paul F Jacobson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Paul F Jacobson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul F Jacobson has 0.
Where does Paul F Jacobson file Form 4?
Paul F Jacobson has filed Form 4 at THRN (Thorne Healthtech, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.